NewsOK Local Stocks
Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Local Stocks
Nektar Therapeutics (NQ: NKTR)
32.09 USD  -0.25 (-0.77%)
Official Closing Price  /  Updated: 5:34 PM EDT, Jul 23, 2019  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 695,700
Open 32.39
Bid (Size) 31.02 (1)
Ask (Size) 32.99 (2)
Prev. Close 32.34
Today's Range 31.91 - 32.39
52wk Range 29.22 - 69.76
Shares Outstanding 171,402,476
Dividend Yield N/A
Performance
YTD
-6.22%
-6.22%
1 Month
-5.31%
-5.31%
3 Month
+1.49%
+1.49%
6 Month
-28.31%
-28.31%
1 Year
-35.00%
-35.00%
Top News
More News
First-in-Human Data Presented from Phase 1a Study of NKTR-358, a Novel T Regulatory Cell Stimulator, at Annual European Congress of Rheumatology
Nektar Therapeutics (Nasdaq: NKTR) today announced the results of the first-in-human Phase 1a study evaluating single-ascending doses of NKTR-358, a first-in-class T regulatory cell stimulator in... Read More
from PR Newswire
Nektar Therapeutics to Host Webcast Conference Call with Immunology Expert for Analysts & Investors During 2019 European Congress of Rheumatology (EULAR 2019)
Nektar Therapeutics (NASDAQ:NKTR) announced today that it will webcast an analyst and investor conference call with an immunology expert and company management on Thursday, June 13, 2019 at 8:00 a.m.... Read More
from PR Newswire
More News
Read More
Oshkosh Larger Than S&P 500 Component Nektar Therapeutics
category Stocks
from Market News Video
Encompass Health Larger Than S&P 500 Component Nektar Therapeutics
category Stocks
from Market News Video
LendingClub Moves Up In Market Cap Rank, Passing Nektar Therapeutics
category Stocks
from Market News Video
August 23rd Options Now Available For Nektar Therapeutics (NKTR)
category Stocks
from Market News Video
August 9th Options Now Available For Nektar Therapeutics (NKTR)
category Stocks
from Market News Video
Wednesday's ETF Movers: XOP, PXMG
category ETFs
from ETF Channel
Here's Why Nektar Therapeutics Stock Gained 13.6% in June
category Market News , NKTR , BMY
from Motley Fool
Are Natural Killer Cells the Next Big Thing in Immunotherapy?
category GILD , NKTR , MRK , and 4 more.
from Motley Fool
Harry Boxer’s three biotech stocks on the move include Nektar Therapeutics
category NKTR , Biotechnology , GTHX , and 4 more.
from MarketWatch
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.